Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Spectrum Announces Asset Purchase and License for a Novel Immuno-Oncology Platform including Two Early Stage Assets

firstwordpharmaMay 10, 2019

Tag: Spectrum , Immuno-Oncology

PharmaSources Customer Service